Common cholesteryl ester transfer protein gene polymorphisms and the effect of atorvastatin therapy in type 2 diabetes

Diabetes Care

Volumn 26, Issue 4, 2003, Pages 1216-1223

  Van Venrooij, Francine V ^a   Stolk, Ronald P ^a   Banga, Jan Dirk ^a   Sijmonsma, Tjeerd P ^a   Van Tol, Arie ^b   Erkelens, D Willem ^a   Dallinga Thie, Geesje M ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^b ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ATORVASTATIN; CHOLESTEROL ESTER TRANSFER PROTEIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LIPID; RESTRICTION ENDONUCLEASE; TAQ POLYMERASE; TAQ1B POLYMERASE; UNCLASSIFIED DRUG;

ADULT; AGED; ALLELE; ARTICLE; CHOLESTEROL BLOOD LEVEL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOSE RESPONSE; DOUBLE BLIND PROCEDURE; DRUG EFFECT; DRUG RESPONSE; ENZYME ACTIVITY; FEMALE; GENE SEQUENCE; GENETIC POLYMORPHISM; GENETIC VARIABILITY; HETEROZYGOTE; HUMAN; LIPOPROTEIN BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; NON INSULIN DEPENDENT DIABETES MELLITUS; PATIENT SELECTION; PROMOTER REGION; RANDOMIZED CONTROLLED TRIAL; SEQUENCE ANALYSIS;

AGED; BASE SEQUENCE; CARRIER PROTEINS; CHOLESTEROL; CHOLESTEROL ESTER TRANSFER PROTEINS; CHOLESTEROL ESTERS; DIABETES MELLITUS, TYPE 2; DNA PRIMERS; DOUBLE-BLIND METHOD; FEMALE; GENOTYPE; GLYCOPROTEINS; HEMOGLOBIN A, GLYCOSYLATED; HEPTANOIC ACIDS; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; MALE; MIDDLE AGED; PATIENT SELECTION; PLACEBOS; POLYMORPHISM, GENETIC; PYRROLES; RESTRICTION MAPPING; TRIGLYCERIDES;

EID: 0042167480     PISSN: 01495992     EISSN: None     Source Type: Journal    
DOI: 10.2337/diacare.26.4.1216     Document Type: Article

References (28)

1. Yamashita S, Hirano K, Sakai N, Matsuzawa Y: Molecular biology and pathophysiological aspects of plasma cholesteryl ester transfer protein. Biochim Biophys Acta Mol Cell Biol Lipids 1529:257-275, 2000
2. McPherson R, Mann CJ, Tall AR, Hogue M, Martin L, Milne RW, Marcel YL: Plasma concentrations of cholesteryl ester transfer protein in hyperlipoproteinemia. Arterioscler Thromb 11:797-803, 1991
3. Tall AR: Plasma cholesteryl transfer protein. J Lipid Res 34:1255-1275, 1993
4. Morton RE: Cholesteryl ester transfer protein and its plasma regulator: lipid transfer inhibitor protein. Curr Opin Lipidol 10: 321-327, 1999
5. Swenson TL: Transfer proteins in reverse cholesterol transport. Curr Opin Lipidol 3:67-74, 1992
6. Guerin M, Le Goff W, Lassel TS, Van Tol A, Steiner G, Chapman MJ: Proatherogenic role of elevated cholesteryl ester transfer from HDL to VLDL1 and dense LDL in type 2 diabetes: impact of the degree of triglyceridemia. Arterioscler Thromb Vase Biol 21:282-288, 2001
7. Riemens S, Van Tol A, Sluiter W, Dullaart R: Elevated plasma cholesteryl ester transfer in NIDDM: relationships with apolipoprotein B-containing lipoproteins and phospholipid transfer protein. Atherosclerosis 140:71-79, 1998
8. Bhatnagar D, Durrington P, Kumar S, Mackness MI, Dean J, Boulton AJ: Effect of treatment with a hydroxymethylglutaryl coenzyme A reductase inhibitor on fasting and postprandial plasma lipoproteins and cholesteryl ester transfer activity in patients with NIDDM. Diabetes 44: 460-465, 1995
9. Desrumaux C, Athias A, Bessède G, Vergès B, Famier M, Perségol L, Gambert P, Lagrost L: Mass concentration of plasma phospholipid transfer protein in normolipidemic, type IIa hyperlipidemic, type IIb hyperlipidemic, and non-insulin-dependent diabetic subjects as measured by a specific ELISA. Arterioscler Thromb Vasc Biol 19:266-275, 1999
10. Lottenberg SA, Lottenberg AM, Nunes VS, McPherson R, Quintao EC: Plasma cholesteryl ester transfer protein concentration, high-density lipoprotein cholesterol esterification and transfer rates to lighter density lipoproteins in the fasting state and after a test meal are similar in type II diabetics and normal controls. Atherosclerosis 127:81-90, 1996
11. Durlach A, Clavel C, Girard-Globa A, Durlach V: Sex-dependent association of a genetic polymorphism of cholesteryl ester transfer protein with high-density lipoprotein cholesterol and macrovascular pathology in type II diabetic patients. J Clin Endocrinol Metab 84:3656-3659, 1999
12. Kahri J, Syvanne M, Taskinen MR: Plasma cholesteryl ester transfer protein activity in non-insulin-dependent diabetic patients with and without coronary artery disease. Metabolism 43:1498-1502, 1994
13. Kuivenhoven JA, Jukema JW, Zwinderman AH, de KP, McPherson R, Bruschke AV, Lie KI, Kastelein JJ: The role of a common variant of the cholesteryl ester transfer protein gene in the progression of coronary atherosclerosis: the Regression Growth Evaluation Statin Study Group [see comments]. N Engl J Med 338:86-93, 1998
14. Ordovas J, Cupples LA, Corella D, Otvos JD, Osgood D, Martinez A, Lahoz C, Coltell O, Wilson PW, Schaefer EJ: Association of cholesteryl ester transfer protein-TaqIB polymorphism with variations in lipoprotein subclasses and coronary heart disease risk: the Framingham study. Arterioscler Thromb Vasc Biol 20:1323-1329, 2000
15. Dachet C, Poirier O, Cambien F, Chapman J, Rouis M: New functional promoter polymorphism, CETP/-629, in cholesteryl, ester transfer protein (CETP) gene related to CETP mass and high density lipoprotein cholesterol levels: role of Sp1/Sp3 in transcriptional regulation. Arterioscler Thromb Vasc Biol 20:507-515, 2000
16. Corbex M, Poirier O, Fumeron F, Betoulle D, Evans A, Ruidavets JB, Arveiler D, Luc G, Tiret L, Cambien F: Extensive association analysis between the CETP gene phenotypes reveals several putative functional polymorphisms and gene-environment interaction. Genet Epidemiol 19:64-80, 2000
17. The Diabetes Atorvastatin Lipid Intervention (DALI) Study Group: The effect of aggressive versus standard lipid lowering by atorvastatin on diabetic dyslipidemia: the DALI study: a double-blind randomized, placebo - controlled trial in patients with type 2 and diabetic dyslipidemia. Diabetes Care 24:1335-1341, 2001
18. The Expert Committee on the Diagnosis and Classification of Diabetes Mellitus: Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Diabetes Care 20:1183-1197, 1997
19. Niemeijer-Kanters SDJM, Dallinga-Thie GM, Ruijter-Heijstek FC, Algra A, Erkelens DW, Banga JD, Jansen H: Effect of intensive lipid-lowering strategy on low-density lipoprotein particle size in patients with type 2 diabetes mellitus. Atherosclerosis 156:209-216, 2001
20. Speijer H, Groener JE, van Ramshorst E, Van Tol A: Different locations of cholesteryl ester transfer protein and phospholipid transfer protein activities in plasma. Atherosclerosis 90:159-168, 1991
21. Miller SA, Dykes DD, Polesky HF: A simple salting out procedure for extracting DNA from human nucleated cells. Nucl Acids Res 16:1215, 1988
22. Le Goff W, Guerin M, Nicaud V, Dachet C, Luc G, Arveiler D, Ruidavets J-B, Evans A, Kee F, Morrison C, Chapman MJ, Thillet J: A novel cholesteryl ester transfer protein promoter polymorphism (-971 G/A) associated with plasma high-density lipoprotein cholesterol levels. Interaction with the Taq! B and -629 C/A polymorphisms. Atherosclerosis 161:269-279, 2002
23. Kauma H, Sarvolainen MJ, Heikkila R, Rantala A, Lilja M, Reunanen A, Kesaniemi YA: Sex difference in the regulation of plasma high density lipoprotein cholesterol by genetic and environmental factor. Hum Genet 97:156-162, 1996
24. Oliveira HCF, Chouinard RA, Agellon LB, Bruce C, Ma LM, Walsh A, Breslow JL, Tall AR: Human cholesteryl ester transfer protein gene proximal promoter contains dietary cholesterol positive responsive elements and mediates expression in small intestine and periphery while predominant liver and spleen expression is controlled by 5'-distal sequences. Cis-acting sequences mapped in transgenic mice. J Biol Chem 271:31831-31838, 1996
25. Gauthier B, Robb M, McPherson R: Cholesteryl ester transfer protein gene expression during differentiation of human preadipocytes to adipocytes in primary culture. Atherosclerosis 142:301-307, 1999
26. Brown MS, Goldstein JL: A proteolytic pathway that controls the cholesterol content of membranes, cells, and blood. Proc Natl Acad Sci U S A 96:11041-11048, 1999
27. Chouinard RA, Luo Y, Osbome TF, Walsh A, Tall AR: Sterol regulatory element binding protein-1 activates the cholesteryl ester transfer protein gene in vivo but is not required for sterol up-regulation of gene expression. J Biol Chem 273: 22409-22414, 1998
28. Gauthier B, Robb M, Gaudet F, Ginsburg GS, McPherson R: Characterization of a cholesterol response element (CRE) in the promoter of the cholesteryl ester transfer protein gene: functional role of the transcription factors SREBP-1a, -2, and YY1. J Lipid Res 40:1284-1293, 1999